Skip to content
NYSE: IGC | Borse Berlin: IGS1.BE | Frankfurt: IGS1
IGC

IGC

India Globalization Capital Inc.

  • Home
  • Life Sciences
  • Infrastructure Business
  • Investors
    • Press Releases
    • SEC Filings
    • Leadership
    • XBRL Files
    • Governance

IGC Acquires Exclusive Rights for a Potential Alzheimer’s
Drug Development Candidate

June 21, 2022June 21, 2022 by Alejandro
Posted in News and Filings, Press Releases

Post navigation

← IGC Form 8-K
IGC Reports Financial Results for Fiscal Year Ended March 31, 2022 →

Site Map

  • Home
  • Life Sciences
  • Infrastructure Business
  • Investors
    • Press Releases
    • SEC Filings
    • Leadership
    • XBRL Files
    • Governance

Contact

IGC
Potomac, MD, United States

info@igcinc.us
301-983-0998